Helius Medical Technologies, Inc. is a neurotech company in the medical device field. It is focused on neurologic deficits using orally applied technology platform that amplifies the brain’s ability to engage physiologic compensatory mechanisms enhancing the lives of people dealing with neurologic diseases. It develops, licenses, or acquires non-implantable technologies targeted at reducing symptoms of neurological disease or trauma. Its product Portable Neuromodulation Stimulator (PoNS) is a non-implantable medical device, inclusive of a controller and mouthpiece, which delivers mild electrical stimulation to the surface of the tongue to provide treatment of gait deficit and chronic balance deficit. PoNS Therapy is integral to the overall PoNS solution and is the physical therapy applied by patients during use of the PoNS neuromodulation stimulator. PoNS is used as an adjunct to a supervised therapeutic exercise program in patients 22 years of age and over by prescription only.
종목 코드 HSDT
회사 이름Helius Medical Technologies Inc
상장일Jun 27, 2014
CEOMr. Dane C. Andreeff
직원 수21
유형Ordinary Share
회계 연도 종료Jun 27
주소642 Newtown Yardley Road
도시NEWTOWN
증권 거래소NASDAQ Capital Market Consolidated
국가United States of America
우편 번호18940
전화12159446100
웹사이트https://heliusmedical.com/
종목 코드 HSDT
상장일Jun 27, 2014
CEOMr. Dane C. Andreeff
지난 5년 동안 총
0.00
USD의 배당금이 분배되었습니다.

데이터 없음